Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Treiber

Showing results (131-140 of 909) with videos related to

Pageof 91
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2007
Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafilAlexander Treiber, Ralph Schneiter, Stephanie Häusler, et al.
Helicobacter|April 18, 1998
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradicationG Treiber, S Ammon, E Schneider, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the ratAlexander Treiber, Ralph Schneiter, Stephane Delahaye, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 13, 2005
Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometryUte Hofmann, Matthias Schwab, Gerd Treiber, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pyloriMatthias Schwab, Elke Schaeffeler, Ulrich Klotz, et al.
International Journal of Dermatology|September 8, 2007
Postoperative electron beam radiotherapy for keloids: objective findings and patient satisfaction in self-assessmentMarc Bischof, Robert Krempien, Juergen Debus, et al.
Zeitschrift Fur Gastroenterologie|May 16, 2007
Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancerG Treiber, C Röcken, T Wex, et al.
Pharmacology Research & Perspectives|July 3, 2020
The endothelin receptor antagonist macitentan for the treatment of pulmonary arterial hypertension: A cross-species comparison of its cytochrome P450 induction patternAlexander Treiber, Stephane Delahaye, Swen Seeland, et al.
Molecular Cell|April 22, 2017
A Compendium of RNA-Binding Proteins that Regulate MicroRNA BiogenesisThomas Treiber, Nora Treiber, Uwe Plessmann, et al.
Pediatrics|March 11, 1998
Cardiovascular reactivity and adolescent boys' physical healthP L Dobkin, R E Tremblay, F A Treiber
Pageof 91

Showing results (131-140 of 909) with videos related to

Sort By:
Pageof 91
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2007
Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafilAlexander Treiber, Ralph Schneiter, Stephanie Häusler, et al.
Helicobacter|April 18, 1998
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradicationG Treiber, S Ammon, E Schneider, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2003
Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the ratAlexander Treiber, Ralph Schneiter, Stephane Delahaye, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 13, 2005
Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometryUte Hofmann, Matthias Schwab, Gerd Treiber, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pyloriMatthias Schwab, Elke Schaeffeler, Ulrich Klotz, et al.
International Journal of Dermatology|September 8, 2007
Postoperative electron beam radiotherapy for keloids: objective findings and patient satisfaction in self-assessmentMarc Bischof, Robert Krempien, Juergen Debus, et al.
Zeitschrift Fur Gastroenterologie|May 16, 2007
Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancerG Treiber, C Röcken, T Wex, et al.
Pharmacology Research & Perspectives|July 3, 2020
The endothelin receptor antagonist macitentan for the treatment of pulmonary arterial hypertension: A cross-species comparison of its cytochrome P450 induction patternAlexander Treiber, Stephane Delahaye, Swen Seeland, et al.
Molecular Cell|April 22, 2017
A Compendium of RNA-Binding Proteins that Regulate MicroRNA BiogenesisThomas Treiber, Nora Treiber, Uwe Plessmann, et al.
Pediatrics|March 11, 1998
Cardiovascular reactivity and adolescent boys' physical healthP L Dobkin, R E Tremblay, F A Treiber
Pageof 91